MMP24OS
gene geneOn this page
Summary
MMP24OS (MMP24 opposite strand, HGNC:44421) is a protein-coding gene on chromosome 20q11.22, encoding Protein MMP24OS (A0A0U1RRL7).
At a glance
- GWAS associations: 11
- MANE Select transcript:
NM_001355003
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:44421 |
| Approved symbol | MMP24OS |
| Name | MMP24 opposite strand |
| Location | 20q11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000126005 |
| Ensembl biotype | protein_coding |
| Entrez | 101410538 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 9 protein_coding_CDS_not_defined, 6 protein_coding, 1 nonsense_mediated_decay
ENST00000424358, ENST00000433764, ENST00000435366, ENST00000438751, ENST00000453892, ENST00000454184, ENST00000455178, ENST00000456350, ENST00000456790, ENST00000566203, ENST00000594413, ENST00000635104, ENST00000864430, ENST00000864431, ENST00000864432, ENST00000864433
RefSeq mRNA: 2 — MANE Select: NM_001355003
NM_001355003, NM_001355004
CCDS: CCDS86948
Canonical transcript exons
ENST00000456790 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001595144 | 35276352 | 35277932 |
| ENSE00002622133 | 35278009 | 35278122 |
Expression profiles
Bgee: expression breadth ubiquitous, 278 present calls, max score 96.92.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 132.2444 / max 1235.2277, expressed in 1816 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187034 | 132.2444 | 1816 |
Top tissues by expression
284 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adenohypophysis | UBERON:0002196 | 96.92 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.83 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.74 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.67 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.65 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 96.45 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 95.86 | gold quality |
| cingulate cortex | UBERON:0003027 | 95.84 | gold quality |
| amygdala | UBERON:0001876 | 95.79 | gold quality |
| right frontal lobe | UBERON:0002810 | 95.77 | gold quality |
| pituitary gland | UBERON:0000007 | 95.71 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.58 | gold quality |
| apex of heart | UBERON:0002098 | 95.54 | gold quality |
| cerebellum | UBERON:0002037 | 95.50 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 95.49 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.42 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.42 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 95.38 | gold quality |
| nucleus accumbens | UBERON:0001882 | 95.31 | gold quality |
| ileal mucosa | UBERON:0000331 | 95.28 | gold quality |
| putamen | UBERON:0001874 | 95.11 | gold quality |
| adrenal cortex | UBERON:0001235 | 95.03 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 94.92 | gold quality |
| ascending aorta | UBERON:0001496 | 94.74 | gold quality |
| thoracic aorta | UBERON:0001515 | 94.74 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 94.61 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 94.59 | gold quality |
| hypothalamus | UBERON:0001898 | 94.58 | gold quality |
| right uterine tube | UBERON:0001302 | 94.44 | gold quality |
| mucosa of stomach | UBERON:0001199 | 94.42 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.02 |
| E-MTAB-8530 | no | 573.90 |
| E-ENAD-27 | no | 3.36 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Protein MMP24OS — A0A0U1RRL7 (reviewed: A0A0U1RRL7)
Alternative names: MMP24 opposite strand
All UniProt accessions (1): A0A0U1RRL7
RefSeq proteins (2): NP_001341932, NP_001341933 (=MANE)
Domains & families (InterPro)
UniProt features (4 total): compositionally biased region 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A0U1RRL7-F1 | 69.77 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN, NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN, BASAKI_YBX1_TARGETS_DN, TIEN_INTESTINE_PROBIOTICS_2HR_UP, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN, chr20q11, DODD_NASOPHARYNGEAL_CARCINOMA_DN, TIEN_INTESTINE_PROBIOTICS_6HR_UP, CHICAS_RB1_TARGETS_CONFLUENT, JOHNSTONE_PARVB_TARGETS_3_UP, BAKKER_FOXO3_TARGETS_DN, E2F1_UP.V1_DN, GLI1_TARGET_GENES, RBM34_TARGET_GENES, SNRNP70_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
60 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MMP24OS | MMP27 | Q9H306 | 366 |
| MMP24OS | MMP26 | Q9NRE1 | 349 |
| MMP24OS | MMP17 | Q9ULZ9 | 310 |
| MMP24OS | MMP20 | O60882 | 305 |
| MMP24OS | MMP23B | O75900 | 276 |
| MMP24OS | MMP19 | Q99542 | 274 |
| MMP24OS | LCE2C | Q5TA81 | 274 |
| MMP24OS | LCE2A | Q5TA79 | 270 |
| MMP24OS | LCE1E | Q5T753 | 264 |
| MMP24OS | FBXL8 | Q96CD0 | 259 |
| MMP24OS | MMP25 | Q9NPA2 | 258 |
| MMP24OS | MMP28 | Q9H239 | 248 |
| MMP24OS | MMP24 | Q9Y5R2 | 247 |
| MMP24OS | LCE1D | Q5T752 | 246 |
| MMP24OS | LCE1A | Q5T7P2 | 246 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AFG2B | MMP24OS | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A0U1RRL7, A0A286YF18, A0JWY5, A1L429, A6NDE8, A6NER3, A8WFF7, B1ARW8, B8H8L5, E9PXT9, O76087, P04487, P06924, P0C675, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P22157, P25483, P26550, P56958, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q1HVH9, Q32LJ5, Q3KSU8, Q4V321, Q4V326, Q66619, Q66659, Q6NT46, Q7YR45
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2439 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:35246987:GA:G | donor_gain | 1.0000 |
| 20:35246989:G:GG | donor_gain | 1.0000 |
| 20:35263922:G:GT | donor_gain | 1.0000 |
| 20:35263949:TATGG:T | donor_loss | 1.0000 |
| 20:35263950:ATGGT:A | donor_loss | 1.0000 |
| 20:35263953:GT:G | donor_loss | 1.0000 |
| 20:35263954:T:A | donor_loss | 1.0000 |
| 20:35263964:G:GT | donor_gain | 1.0000 |
| 20:35267415:TTAAG:T | donor_loss | 1.0000 |
| 20:35267416:TAAG:T | donor_loss | 1.0000 |
| 20:35267417:AAG:A | donor_loss | 1.0000 |
| 20:35267418:AGGTA:A | donor_loss | 1.0000 |
| 20:35267419:GGTA:G | donor_loss | 1.0000 |
| 20:35267420:GT:G | donor_loss | 1.0000 |
| 20:35267421:T:A | donor_loss | 1.0000 |
| 20:35269747:C:A | acceptor_gain | 1.0000 |
| 20:35269757:CA:C | acceptor_loss | 1.0000 |
| 20:35269758:A:AG | acceptor_gain | 1.0000 |
| 20:35269758:AG:A | acceptor_gain | 1.0000 |
| 20:35269758:AGGAT:A | acceptor_loss | 1.0000 |
| 20:35269759:G:A | acceptor_gain | 1.0000 |
| 20:35269759:G:GT | acceptor_gain | 1.0000 |
| 20:35269759:GGA:G | acceptor_gain | 1.0000 |
| 20:35269759:GGAT:G | acceptor_gain | 1.0000 |
| 20:35269759:GGATC:G | acceptor_gain | 1.0000 |
| 20:35269896:AAGGT:A | donor_loss | 1.0000 |
| 20:35269899:G:GC | donor_loss | 1.0000 |
| 20:35271829:G:GT | donor_gain | 1.0000 |
| 20:35271830:A:T | donor_gain | 1.0000 |
| 20:35271831:AGGAT:A | donor_gain | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000542184 (20:35277938 A>G), RS1000587713 (20:35277647 G>A), RS1001766559 (20:35277360 G>A), RS1002111141 (20:35277595 C>A), RS1003089548 (20:35278409 C>A), RS1003549902 (20:35278645 C>G), RS1003844290 (20:35275958 G>A), RS1005342289 (20:35278512 G>T), RS1006166806 (20:35278377 G>A), RS1006354941 (20:35280073 T>C), RS1006708324 (20:35277967 C>T), RS1007024468 (20:35278108 C>A), RS1008121475 (20:35278995 G>A), RS1008284943 (20:35276872 G>A), RS1008807237 (20:35276483 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
11 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008163_596 | Height | 3.000000e-06 |
| GCST012227_1095 | Hip circumference adjusted for BMI | 2.000000e-42 |
| GCST012227_1096 | Hip circumference adjusted for BMI | 2.000000e-12 |
| GCST012227_1097 | Hip circumference adjusted for BMI | 2.000000e-29 |
| GCST012228_446 | Waist-hip index | 2.000000e-17 |
| GCST012228_447 | Waist-hip index | 8.000000e-12 |
| GCST012230_187 | Waist-to-hip ratio adjusted for BMI | 3.000000e-20 |
| GCST012230_188 | Waist-to-hip ratio adjusted for BMI | 2.000000e-13 |
| GCST012231_11 | A body shape index | 3.000000e-13 |
| GCST90020028_1524 | Hip circumference adjusted for BMI | 3.000000e-18 |
| GCST90020028_1525 | Hip circumference adjusted for BMI | 6.000000e-10 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008039 | BMI-adjusted hip circumference |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0007789 | BMI-adjusted waist circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | decreases expression, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| Diuron | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Propofol | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.